Scholars@Duke publication: Successful conversion from conventional immunosuppression to anti-CD40 ligand therapy in a non-human primate model.

Successful conversion from conventional immunosuppression to anti-CD40 ligand therapy in a non-human primate model.

Publication , Conference

Knechtle, SJ; Burkley, LC; Fechner, JH; Brunner, K; Dong, YC; Cho, CS; Nadeau, K; TenHoor, C; Hamawy, MM

Published in: TRANSPLANTATION

April 27, 2000

TRANSPLANTATION

0041-1337

April 27, 2000

S123 / S123

LIPPINCOTT WILLIAMS & WILKINS

APA

Chicago

ICMJE

MLA

NLM

Knechtle, S. J., Burkley, L. C., Fechner, J. H., Brunner, K., Dong, Y. C., Cho, C. S., … Hamawy, M. M. (2000). Successful conversion from conventional immunosuppression to anti-CD40 ligand therapy in a non-human primate model. In TRANSPLANTATION (Vol. 69, pp. S123–S123). LIPPINCOTT WILLIAMS & WILKINS.

Knechtle, S. J., L. C. Burkley, J. H. Fechner, K. Brunner, Y. C. Dong, C. S. Cho, K. Nadeau, C. TenHoor, and M. M. Hamawy. “Successful conversion from conventional immunosuppression to anti-CD40 ligand therapy in a non-human primate model.” In TRANSPLANTATION, 69:S123–S123. LIPPINCOTT WILLIAMS & WILKINS, 2000.

Knechtle SJ, Burkley LC, Fechner JH, Brunner K, Dong YC, Cho CS, et al. Successful conversion from conventional immunosuppression to anti-CD40 ligand therapy in a non-human primate model. In: TRANSPLANTATION. LIPPINCOTT WILLIAMS & WILKINS; 2000. p. S123–S123.

Knechtle, S. J., et al. “Successful conversion from conventional immunosuppression to anti-CD40 ligand therapy in a non-human primate model.” TRANSPLANTATION, vol. 69, no. 8, LIPPINCOTT WILLIAMS & WILKINS, 2000, pp. S123–S123.

Knechtle SJ, Burkley LC, Fechner JH, Brunner K, Dong YC, Cho CS, Nadeau K, TenHoor C, Hamawy MM. Successful conversion from conventional immunosuppression to anti-CD40 ligand therapy in a non-human primate model. TRANSPLANTATION. LIPPINCOTT WILLIAMS & WILKINS; 2000. p. S123–S123.

TRANSPLANTATION

0041-1337

April 27, 2000

S123 / S123

LIPPINCOTT WILLIAMS & WILKINS